SG, K., S, P., C, J., MA, R., M, M., M, R., . . . C, J. (2014). Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
Citación estilo ChicagoSG, Kalko, et al. Transcriptomic Profiling of TK2 Deficient Human Skeletal Muscle Suggests a Role for the P53 Signalling Pathway and Identifies Growth and Differentiation Factor-15 As a Potential Novel Biomarker for Mitochondrial Myopathies. 2014.
Cita MLASG, Kalko, et al. Transcriptomic Profiling of TK2 Deficient Human Skeletal Muscle Suggests a Role for the P53 Signalling Pathway and Identifies Growth and Differentiation Factor-15 As a Potential Novel Biomarker for Mitochondrial Myopathies. 2014.